Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/20124171

J. Clin. Oncol. 2010 Mar 10 28 8 1287-93

Download in:

View as

General Info

PMID
20124171